The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1LIFE HEALTHCARE INC | COM | 68269G107 | 4,832 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
ABBOTT LABS | COM | 002824100 | 9,852 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
ABBVIE INC | COM | 00287Y109 | 6,770 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ACADIA HEALTHCARE COMPANY IN | COM | 00404A109 | 7,284 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,908 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AGILON HEALTH INC | COM | 00857U107 | 3,375 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 1,798 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 1,163 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 3,392 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 674 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AMEDISYS INC | COM | 023436108 | 8,094 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 2,021 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 11,589 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 5,674 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
ARCTURUS THERAPEUTICS HLDGS | COM | 03969T109 | 2,406 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 3,315 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 5,825 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 3,152 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AVALO THERAPEUTICS INC | COM | 05338F108 | 2,763 | 1,625,000 | SH | SOLE | 1,625,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 8,397 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 4,241 | 48,000 | SH | SOLE | 48,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 8,033 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | CALL | 10806X902 | 2,502 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
CENTENE CORP DEL | COM | 15135B101 | 18,540 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 7,282 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 707 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
CVS HEALTH CORP | COM | 126650100 | 8,769 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 14,814 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
DENALI THERAPEUTICS INC | COM | 24823R105 | 4,460 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
EDWARDS LIFESCIENCES CORP | COM | 28176E108 | 5,830 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
ENVISTA HOLDINGS CORPORATION | COM | 29415F104 | 13,518 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 7,606 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
FORMA THERAPEUTICS HLDGS INC | SHS | 34633R104 | 1,067 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 4,410 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
GLOBUS MED INC | CL A | 379577208 | 12,996 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
HERON THERAPEUTICS INC | COM | 427746102 | 6,848 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 3,233 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 1,855 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 2,202 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 2,179 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 5,912 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 1,222 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 4,708 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 2,328 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 2,048 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 1,648 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 1,190 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
LABORATORY CORP AMER HLDGS | COM NEW | 50540R409 | 6,284 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
LEXICON PHARMACEUTICALS INC | COM NEW | 528872302 | 788 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
LONGBOARD PHARMACEUTICALS IN | COM | 54300N103 | 146 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
LYELL IMMUNOPHARMA INC | COM | 55083R104 | 1,084 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 2,087 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 399 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
MASIMO CORP | COM | 574795100 | 2,928 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 13,671 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,595 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
MYOVANT SCIENCES LTD | COM | G637AM102 | 389 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 2,837 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
PERKINELMER INC | COM | 714046109 | 14,074 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
PFIZER INC | COM | 717081103 | 11,810 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
PRECISION BIOSCIENCES INC | COM | 74019P108 | 1,295 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 1,792 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 2,716 | 103,000 | SH | SOLE | 103,000 | 0 | 0 | ||
REGENXBIO INC | COM | 75901B107 | 2,453 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 6,910 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 2,710 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 17,399 | 409,000 | SH | SOLE | 409,000 | 0 | 0 | ||
SI-BONE INC | COM | 825704109 | 3,887 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 6,535 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 2,074 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 10,087 | 120,000 | SH | SOLE | 120,000 | 0 | 0 |